4.6 Article

Current Regulatory and Legal Considerations for Follow-On Biologics

Related references

Note: Only part of the references are listed.
Article Biotechnology & Applied Microbiology

Opinion - The FDA's assessment of follow-on protein products: a historical perspective

Janet Woodcock et al.

NATURE REVIEWS DRUG DISCOVERY (2007)

Article Health Care Sciences & Services

'Follow-on biologics': Ensuring continued innovation in the biotechnology industry

BS Manheim et al.

HEALTH AFFAIRS (2006)

Article Medicine, General & Internal

Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.

N Casadevall et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)